▟ Vinebot intrinsic value, daily

← back

BRO Brown & Brown

insurance · valued with opus medium conviction · deep-dived 2026-11-11

HOLD
Intrinsic value$52.60
Price (at call)$71.89
Margin of safety -26.8%
vs market (rating basis) -4.9%

Quality broker priced above its goodwill-heavy book's returns; the rally widens the premium again.

The story

Brown & Brown is a top-tier, capital-light insurance broker with high organic-growth discipline and roughly 29-32% operating margins. After the Accession deal the book is heavily goodwill, so reported ROE (9.7% trailing) understates the returns on tangible capital. Margins slipped to 29.1% on deal costs and a softening P&C pricing cycle, so integration has to deliver before ROE on the enlarged book rises.

Drivers are unchanged. Trailing ROE of 9.7% is close to the 10.2% normalized figure, which assumes modest synergy capture on the goodwill-inflated equity base. Book growth reflects retained earnings plus tuck-in M&A, with a terminal rate below the 4.98% risk-free rate. Beta stays just under the 0.9 industry anchor because broker fee income is not exposed to underwriting risk.

Value drivers

Return on equity (normalized)10.2%
Book-value growth (Y1)6.5%
Terminal book growth4.5%
Beta0.82
Failure probability0.5%
Cost of equity8.7%

Valuation bridge

PV of excess returns1.58B
PV of terminal excess3.41B
Equity value17.45B
÷ shares → per share$52.60

Projected excess returns on equity

YrBook equityROEExcess returnPV
112.55B 10.2%191.59M 176.30M
213.36B 10.2%204.05M 172.78M
314.20B 10.2%216.86M 168.97M
415.06B 10.2%229.99M 164.90M
515.94B 10.2%243.40M 160.59M
616.83B 10.2%257.06M 156.07M
717.74B 10.2%270.91M 151.35M
818.66B 10.2%284.91M 146.47M
919.58B 10.2%299.00M 141.44M
1020.51B 10.2%313.12M 136.30M

Key risks

  • Accession integration or producer attrition erodes margins and leaves ROE stuck below 10%
  • Softening P&C rate cycle slows organic growth and commission income
  • Higher leverage and goodwill impairment risk if acquired revenue underperforms

Catalysts

  • Margin recovery toward 32% as deal costs roll off and synergies show up
  • Sustained mid-single-digit organic growth that proves the franchise holds through a soft market

History

DatePriceIntrinsicMoSRating
2026-11-11$71.89 $52.60 -26.8% HOLD
2026-10-09$63.75 $49.03 -23.1% BUY
2026-09-08$71.42 $58.19 -18.5% BUY
2026-08-06$70.95 $57.24 -19.3% BUY
2026-07-03$70.00 $58.92 -15.8% HOLD
2026-06-23$60.40 $61.40 +1.7% BUY